Added to YB: 2026-01-20
Pitch date: 2026-01-17
AVCR.V [neutral]
Avricore Health Inc.
-42.11%
current return
Author Info
No bio for this author
Company Info
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom.
Market Cap
CAD 7.0M
Pitch Price
CAD 0.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.21
P/E
-2.80
EV/Sales
46.76
Sector
Health Care Technology
Category
turnaround
Avricore's Healthtab UK Pivot
AVCR.V (watchlist): Point-of-care testing co pivoting from failed Canada rollout to UK pharmacy partnerships. Expanding London pilot to 70 additional pharmacies, targeting 500+ by end-2026. Dense UK geography advantage vs Canada fragmentation. New CEO focus on execution over hype. Equity raise likely needed 6-18 months creating dilution risk.
Read full article (3 min)